Socio-demographic and drug use factors associated with HIV-1 recombinants and dual infections in Northern Thai drug users: Associations of risk with genetic complexity

Drug and Alcohol Dependence

Volumn 116, Issue 1-3, 2011, Pages 24-30

  Kijak, G H ^a   Beyrer, C ^b   Tovanabutra, S ^a   Sripaipan, T ^b   Suriyanon, V ^c   Moqueet, N ^a   Sanders Buell, E ^a   Saokhieo, P ^c   Timpan, U ^c   Jittiwutikarn, J ^d   Robb, M L ^a   Birx, D L ^a,e   Celentano, D D ^b   McCutchan, F E ^a,f  

^a HENRY M JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c Research Institute for Health Sciences   (Thailand)

^d Northern Drug Treatment Center   (Thailand)

^e CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^f BILL AND MELINDA GATES FOUNDATION   (United States)

Author keywords

Dual infection; HIV AIDS; Injecting risk; Injection drug use; Molecular epidemiology; Multi region hybridization assay; Recombination; Thailand

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; DRUG ABUSE; EDUCATIONAL STATUS; FEMALE; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SOCIAL STATUS; THAILAND; VIRAL GENETICS; VIRUS RECOMBINANT; VIRUS STRAIN; VOLUNTEER;

ADOLESCENT; ADULT; DEMOGRAPHY; DRUG USERS; FEMALE; HIV INFECTIONS; HIV SEROPOSITIVITY; HIV-1; HUMANS; MALE; RISK FACTORS; SOCIOECONOMIC FACTORS; SUBSTANCE ABUSE, INTRAVENOUS; SUBSTANCE-RELATED DISORDERS; THAILAND; YOUNG ADULT;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 79957608737     PISSN: 03768716     EISSN: 18790046     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2010.11.013     Document Type: Article

References (29)

1. Arroyo M.A., Hoelscher M., Sateren W., Samky E., Maboko L., Hoffmann O., Kijak G., Robb M., Birx D.L., McCutchan F.E. HIV-1 diversity and prevalence differ between urban and rural areas in the Mbeya region of Tanzania. AIDS 2005, 19:1517-1524.
2. Arroyo M.A., Sateren W.B., Foglia G., Kibaya R., Langat L., Wasunna M., Bautista C.T., Scott P.T., Shaffer D.N., Robb M.L., Michael N.L., Birx D.L., McCutchan F.E. Short communication: HIV type 1 genetic diversity among tea plantation workers in Kericho, Kenya. AIDS Res. Hum. Retroviruses 2009, 25:1061-1064.
3. Arroyo M.A., Sateren W.B., Serwadda D., Gray R.H., Wawer M.J., Sewankambo N.K., Kiwanuka N., Kigozi G., Wabwire-Mangen F., Eller M., Eller L.A., Birx D.L., Robb M.L., McCutchan F.E. Higher HIV-1 incidence and genetic complexity along main roads in Rakai District, Uganda. J. Acquir. Immune Defic. Syndr. 2006, 43:440-445.
4. Beyrer C., Artenstein A., Kunawararak P., VanCott T., Mason C., Rungreungthanakit K., Hegerich P., Nelson K.E., Khamboonruang C., Natpratan C. The molecular epidemiology of HIV-1 among male sex workers in northern Thailand. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 1997, 15:304-307.
5. Beyrer C., Razak M.H., Jittiwutikarn J., Suriyanon V., Vongchak T., Srirak N., Kawichai S., Tovanabutra S., Rungruengthanakit K., Sawanpanyalert P., Sripaipan T., Celentano D.D. Methamphetamine users in northern Thailand: changing demographics and risks for HIV and STD among treatment-seeking substance abusers. Int. J STD AIDS 2004, 15:697-704.
6. Blick G., Kagan R.M., Coakley E., Petropoulos C., Maroldo L., Greiger-Zanlungo P., Gretz S., Garton T. The probable source of both the primary multidrug-resistant (MDR) HIV-1 strain found in a patient with rapid progression to AIDS and a second recombinant MDR strain found in a chronically HIV-1-infected patient. J. Infect. Dis. 2007, 195:1250-1259.
7. Bunnik E.M., Euler Z., Welkers M.R., Boeser-Nunnink B.D., Grijsen M.L., Prins J.M., Schuitemaker H. Adaptation of HIV-1 envelope gp120 to humoral immunity at a population level. Nat. Med. 2010, 16:995-997.
8. Cheng Y., Sherman S.G., Srirat N., Vongchak T., Kawichai S., Jittiwutikarn J., Suriyanon V., Razak M.H., Sripaipan T., Celentano D.D. Risk factors associated with injection initiation among drug users in Northern Thailand. Harm Reduct. J. 2006, 3:10.
9. Deewong, S., Jitnumshap, P., 2003. Situation of AIDS and symptomatic HIV infection cases in Thailand at January 31, 2003. Weekly Epidemiology Surveillance Report, vol. 34, pp. 165-167.
10. Djoko C.F., Wolfe N.D., Vidal N., Tamoufe U., Montavon C., LeBreton M., Pike B.L., Fair J., Mbacham W.F., Benito A., Rimoin A.W., Saylors K., Mpoudi-Ngole E., Grillo M.P., Peeters M. HIV type 1 pol gene diversity and genotypic antiretroviral drug resistance mutations in Malabo, Equatorial Guinea. AIDS Res. Hum. Retroviruses 2010, 26:1027-1031.
11. Gottlieb G.S., Nickle D.C., Jensen M.A., Wong K.G., Grobler J., Li F., Liu S.L., Rademeyer C., Learn G.H., Karim S.S., Williamson C., Corey L., Margolick J.B., Mullins J.I. Dual HIV-1 infection associated with rapid disease progression. Lancet 2004, 363:619-622.
12. Herbinger K.H., Gerhardt M., Piyasirisilp S., Mloka D., Arroyo M.A., Hoffmann O., Maboko L., Birx D.L., Mmbando D., McCutchan F.E., Hoelscher M. Frequency of HIV type 1 dual infection and HIV diversity: analysis of low- and high-risk populations in Mbeya Region, Tanzania. AIDS Res. Hum. Retroviruses 2006, 22:599-606.
13. Hoelscher M., Dowling W.E., Sanders-Buell E., Carr J.K., Harris M.E., Thomschke A., Robb M.L., Birx D.L., McCutchan F.E. Detection of HIV-1 subtypes, recombinants, and dual infections in east Africa by a multi-region hybridization assay. AIDS 2002, 16:2055-2064.
14. Hu D.J., Subbarao S., Vanichseni S., Mock P.A., Ramos A., Nguyen L., Chaowanachan T., Griensven F., Choopanya K., Mastro T.D., Tappero J.W. Frequency of HIV-1 dual subtype infections, including intersubtype superinfections, among injection drug users in Bangkok, Thailand. AIDS 2005, 19:303-308.
15. Kerr T., Kaplan K., Suwannawaong P., Wood E. Health and human rights in the midst of a drug war. The Thai drug users' network. Public Health and Human Rights 2007 2007, Johns Hopkins University Press. C. Beyrer, H. Pizer (Eds.).
16. Kijak G.H., Tovanabutra S., Sanders-Buell E., Watanaveeradej V., de Souza M.S., Nelson K.E., Ketsararat V., Gulgolgarn V., Wera-arpachai M., Sriplienchan S., Khamboonrueng C., Birx D.L., Robb M.L., McCutchan F.E. Distinguishing molecular forms of HIV-1 in Asia with a high-throughput, fluorescent genotyping assay, MHAbce v.2. Virology 2007, 358:178-191.
17. Kuiken C., Leitner T., Foley B., Hahn B., Marx P., McCutchan F., Wolinsky S., Korber B. HIV Sequence Compendium 2009 2009, Los Alamos National Laboratory Theoretical Biology and Biophysics, Los Alamos, NM.
18. McKinnon L.R., Ball T.B., Kimani J., Wachihi C., Matu L., Luo M., Embree J., Fowke K.R., Plummer F.A. Cross-clade CD8(+) T-cell responses with a preference for the predominant circulating clade. J. Acquir. Immune Defic. Syndr. 2005, 40:245-249.
19. Ramos A., Hu D.J., Nguyen L., Phan K.O., Vanichseni S., Promadej N., Choopanya K., Callahan M., Young N.L., McNicholl J., Mastro T.D., Folks T.M., Subbarao S. Intersubtype human immunodeficiency virus type 1 superinfection following seroconversion to primary infection in two injection drug users. J. Virol. 2002, 76:7444-7452.
20. Razak M.H., Jittiwutikarn J., Suriyanon V., Vongchak T., Srirak N., Beyrer C., Kawichai S., Tovanabutra S., Rungruengthanakit K., Sawanpanyalert P., Celentano D.D. HIV prevalence and risks among injection and noninjection drug users in northern Thailand: need for comprehensive HIV prevention programs. J. Acquir. Immune Defic. Syndr. 2003, 33:259-266.
21. Saathoff E., Pritsch M., Geldmacher C., Hoffmann O., Koehler R.N., Maboko L., Maganga L., Geis S., McCutchan F.E., Kijak G.H., Kim J.H., Arroyo M.A., Gerhardt M., Tovanabutra S., Robb M.L., Williamson C., Michael N.L., Hoelscher M. Viral and host factors associated with the HIV-1 viral load setpoint in adults from Mbeya Region, Tanzania. J. Acquir. Immune Defic. Syndr. 2010, 54:324-330.
22. Smith D.M., Richman D.D., Little S.J. HIV superinfection. J. Infect. Dis. 2005, 192:438-444.
23. Subbarao S., Limpakarnjanarat K., Mastro T.D., Bhumisawasdi J., Warachit P., Jayavasu C., Young N.L., Luo C.C., Shaffer N., Kalish M.L., Schochetman G. HIV type 1 in Thailand, 1994-1995: persistence of two subtypes with low genetic diversity. AIDS Res. Hum. Retroviruses 1998, 14:319-327.
24. Taylor B.S., Sobieszczyk M.E., McCutchan F.E., Hammer S.M. The challenge of HIV-1 subtype diversity. N. Engl. J. Med. 2008, 358:1590-1602.
25. Tovanabutra S., Beyrer C., Sakkhachornphop S., Razak M.H., Ramos G.L., Vongchak T., Rungruengthanakit K., Saokhieo P., Tejafong K., Kim B., De Souza M., Robb M.L., Birx D.L., Jittiwutikarn J., Suriyanon V., Celentano D.D., McCutchan F.E. The changing molecular epidemiology of HIV type 1 among northern Thai drug users, 1999 to 2002. AIDS Res. Hum. Retroviruses 2004, 20:465-475.
26. Tovanabutra S., Kijak G.H., Beyrer C., Gammon-Richardson C., Sakkhachornphop S., Vongchak T., Jittiwutikarn J., Razak M.H., Sanders-Buell E., Robb M.L., Suriyanon V., Birx D.L., Michael N.L., Celentano D.D., McCutchan F.E. Identification of CRF34_01B, a second circulating recombinant form unrelated to and more complex than CRF15_01B, among injecting drug users in northern Thailand. AIDS Res. Hum. Retroviruses 2007, 23:829-833.
27. Tovanabutra S., Polonis V., De Souza M., Trichavaroj R., Chanbancherd P., Kim B., Sanders-Buell E., Nitayaphan S., Brown A., Robb M.R., Birx D.L., McCutchan F.E., Carr J.K. First CRF01_AE/B recombinant of HIV-1 is found in Thailand. AIDS 2001, 15:1063-1065.
28. Vanichseni S., Kitayaporn D., Mastro T.D., Mock P.A., Raktham S., Des Jarlais D.C., Sujarita S., Srisuwanvilai L.O., Young N.L., Wasi C., Subbarao S., Heyward W.L., Esparza L., Choopanya K. Continued high HIV-1 incidence in a vaccine trial preparatory cohort of injection drug users in Bangkok, Thailand. AIDS 2001, 15:397-405.
29. Xiridou M., van Griensven F., Tappero J.W., Martin M., Gurwith M., Vanichseni S., Kittikraisak W., Coutinho R., Choopanya K. The spread of HIV-1 subtypes B and CRF01_AE among injecting drug users in Bangkok, Thailand. J. Acquir. Immune Defic. Syndr. 2007, 45:468-475.